RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Maria del Pilar Aguinaga to Hydroxyurea

Back to Details
This is a "connection" page, showing publications Maria del Pilar Aguinaga has written about Hydroxyurea.
Maria del Pilar Aguinaga
Connection Strength
0.119
Hydroxyurea
  1. Jones KM, Niaz MS, Brooks CM, Roberson SI, Aguinaga MP, Hills ER, Rice VM, Bourne P, Bruce D, Archibong AE. Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints. Int J Environ Res Public Health. 2009 03; 6(3):1124-44.
    View in: PubMed
    Score: 0.083
  2. Roa D, Kopsombut P, Aguinaga MP, Turner EA. Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro. J Clin Lab Anal. 1997; 11(4):208-13.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support